期刊
CURRENT OPINION IN OPHTHALMOLOGY
卷 29, 期 5, 页码 440-444出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ICU.0000000000000500
关键词
blepharospasm; botulinum toxin; orbicularis myectomy; photochromatic modulation
Purpose of review To review new developments in the medical and surgical treatment options for benign essential blepharospasm (BEB). Recent findings Botulinum toxin injections remain the mainstay treatment for BEB with several formulations currently commercially available. Reports in the medical literature support photochromatic modulation for the symptoms of photophobia, as well as oral medications and surgical myectomy for control of the motor signs of eyelid protractor spasm. Summary Although there remains no cure for BEB, several treatment options are available to effectively manage the signs and symptoms of the condition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据